Synopsis
Synopsis
0
JDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-nitro-2-phenoxymethanesulfonanilide
2. Antifloxil
3. Aulin
4. Eskaflam
5. Guaxan
6. Lizepat
7. Mesulid
8. Nexen
9. Nimesil
10. R 805
11. R-805
12. Redaflam
1. 51803-78-2
2. N-(4-nitro-2-phenoxyphenyl)methanesulfonamide
3. Mesulid
4. Aulin
5. Flogovital
6. Sulidene
7. Nimed
8. 4-nitro-2-phenoxymethanesulfonanilide
9. R-805
10. Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)-
11. R 805
12. Nisulid
13. 4'-nitro-2'-phenoxymethanesulfonanilide
14. 4-nitro-2-phenoxy-methanesulfonanilide
15. Nsc-758412
16. Chembl56367
17. Mls000069680
18. V4tkw1454m
19. Methanesulfonanilide, 4'-nitro-2'-phenoxy-
20. Chebi:44445
21. Ncgc00015725-02
22. R805
23. Smr000058484
24. Cas-51803-78-2
25. Dsstox_cid_17250
26. Dsstox_rid_79316
27. Dsstox_gsid_37250
28. Antifloxil
29. Nimesulida
30. Nimesulidum
31. Guaxan
32. Nimesulidum [inn-latin]
33. Nimesulida [inn-spanish]
34. Nim
35. Nimesulide [inn:ban]
36. Sr-01000000218
37. Einecs 257-431-4
38. 4'-nitro-2'-phenoxymethansulfonanilid
39. Brn 2421175
40. Unii-v4tkw1454m
41. Aldoron
42. Nimedex
43. Orthobid
44. Ccris 8225
45. Nise Gel
46. Nimesulide,(s)
47. Prestwick_618
48. Mfcd00079470
49. Spectrum_001577
50. Nimesulide [mi]
51. Nimesulide (jan/inn)
52. Nimesulide [inn]
53. Nimesulide [jan]
54. Opera_id_1247
55. Prestwick0_000194
56. Prestwick1_000194
57. Prestwick2_000194
58. Prestwick3_000194
59. Spectrum2_001541
60. Spectrum3_001576
61. Spectrum4_000178
62. Spectrum5_000964
63. Lopac-n-1016
64. N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide
65. Nimesulide [mart.]
66. Nimesulide [who-dd]
67. Lopac0_000855
68. Schembl24882
69. Bspbio_000147
70. Bspbio_001103
71. Bspbio_003112
72. Kbiogr_000443
73. Kbiogr_000695
74. Kbioss_000443
75. Kbioss_002057
76. Mls001148268
77. Divk1c_000693
78. Spectrum1503231
79. Spbio_001382
80. Spbio_002068
81. N-(4-nitro-2-phenoxyphenyl)
82. Bpbio1_000163
83. Gtpl7401
84. Nim-03
85. Dtxsid3037250
86. Nimesulide [ep Impurity]
87. Bcbcmap01_000034
88. Hms502c15
89. Kbio1_000693
90. Kbio2_000443
91. Kbio2_002057
92. Kbio2_003011
93. Kbio2_004625
94. Kbio2_005579
95. Kbio2_007193
96. Kbio3_000825
97. Kbio3_000826
98. Kbio3_002612
99. Nimesulide [ep Monograph]
100. Nimesulide For Peak Identification
101. Ninds_000693
102. Bio2_000382
103. Bio2_000862
104. Hms1362g05
105. Hms1568h09
106. Hms1792g05
107. Hms1922k17
108. Hms1990g05
109. Hms2089b14
110. Hms2095h09
111. Hms2234k19
112. Hms3262l11
113. Hms3269g17
114. Hms3371j19
115. Hms3403g05
116. Hms3414p09
117. Hms3649a04
118. Hms3655d13
119. Hms3678p07
120. Hms3712h09
121. Hms3884c22
122. Pharmakon1600-01503231
123. Bcp10076
124. Hy-b0363
125. Zinc4617749
126. Tox21_110207
127. Tox21_301850
128. Tox21_500855
129. Bdbm50056999
130. Ccg-39319
131. Ei-287
132. Nsc758412
133. S2040
134. Stl018679
135. Akos015897356
136. Tox21_110207_1
137. Ac-4524
138. Db04743
139. Ks-1277
140. Lp00855
141. Nsc 758412
142. Sdccgsbi-0050831.p004
143. Idi1_000693
144. Idi1_002137
145. Ncgc00015725-01
146. Ncgc00015725-03
147. Ncgc00015725-04
148. Ncgc00015725-05
149. Ncgc00015725-06
150. Ncgc00015725-07
151. Ncgc00015725-08
152. Ncgc00015725-09
153. Ncgc00015725-10
154. Ncgc00015725-11
155. Ncgc00015725-12
156. Ncgc00015725-13
157. Ncgc00015725-15
158. Ncgc00015725-16
159. Ncgc00015725-29
160. Ncgc00021842-03
161. Ncgc00021842-04
162. Ncgc00021842-05
163. Ncgc00021842-06
164. Ncgc00021842-07
165. Ncgc00021842-08
166. Ncgc00255661-01
167. Ncgc00261540-01
168. Bn166246
169. Nimesulide 100 Microg/ml In Acetonitrile
170. Sbi-0050831.p003
171. Db-052029
172. Ab00052332
173. Eu-0100855
174. Ft-0630650
175. N0984
176. Sw196785-3
177. D01049
178. D70376
179. N 1016
180. Q20994
181. Ab00052332-16
182. Ab00052332_17
183. Ab00052332_18
184. N-[4-nitro-2-(phenoxy)phenyl]methanesulfonamide
185. 803n782
186. A828786
187. Sr-01000000218-2
188. Sr-01000000218-6
189. Sr-01000000218-7
190. W-105866
191. Brd-k76775527-001-06-2
192. Brd-k76775527-001-18-7
193. Sr-01000000218-11
194. Nimesulide, European Pharmacopoeia (ep) Reference Standard
195. Nimesulide, Pharmaceutical Secondary Standard; Certified Reference Material
196. Nimesulide For Peak Identification, European Pharmacopoeia (ep) Reference Standard
197. 1364966-82-4
Molecular Weight | 308.31 g/mol |
---|---|
Molecular Formula | C13H12N2O5S |
XLogP3 | 2.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 308.04669266 g/mol |
Monoisotopic Mass | 308.04669266 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 450 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old.
Food, gender and advanced age have negligible effects on nimesulide pharmacokinetics.
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AX - Other antiinflammatory and antirheumatic agents, non-steroids
M01AX17 - Nimesulide
M - Musculo-skeletal system
M02 - Topical products for joint and muscular pain
M02A - Topical products for joint and muscular pain
M02AA - Antiinflammatory preparations, non-steroids for topical use
M02AA26 - Nimesulide
Absorption
Rapidly absorbed following oral administration.
Route of Elimination
Renal (50%), fecal (29%)
Hepatic. Extensive biotransformation, mainly to 4-hydroxynimesulide (which also appears to be biologically active).
1.84.7 hours
The therapeutic effects of Nimesulide are the result of its complete mode of action which targets a number of key mediators of the inflammatory process such as: COX-2 mediated prostaglandins, free radicals, proteolytic enzymes and histamine.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25302
Submission : 2011-08-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20813
Submission : 2007-08-28
Status : Inactive
Type : II
Certificate Number : R1-CEP 2002-046 - Rev 06
Issue Date : 2019-05-03
Type : Chemical
Substance Number : 1548
Status : Valid
Date of Issue : 2019-09-03
Valid Till : 2022-09-02
Written Confirmation Number : WC-251
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15566
Submission : 2001-07-24
Status : Inactive
Type : II
Certificate Number : R1-CEP 2010-377 - Rev 02
Issue Date : 2022-03-01
Type : Chemical
Substance Number : 1548
Status : Valid
Registrant Name : JDW Pharmaceutical Co., Ltd.
Registration Date : 2021-07-30
Registration Number : 20210730-209-J-1083
Manufacturer Name : Helsinn Advanced Synthesis SA (Helsinn/HAS)
Manufacturer Address : Via Industria 24, 6710 Biasca, Switzerland
Certificate Number : R1-CEP 2005-201 - Rev 00
Issue Date : 2014-04-23
Type : Chemical
Substance Number : 1548
Status : Withdrawn by Holder
Certificate Number : R1-CEP 2004-117 - Rev 01
Issue Date : 2015-11-13
Type : Chemical
Substance Number : 1548
Status : Valid
Certificate Number : R1-CEP 2011-310 - Rev 01
Issue Date : 2023-03-13
Type : Chemical
Substance Number : 1548
Status : Valid
Date of Issue : 2022-10-27
Valid Till : 2025-07-22
Written Confirmation Number : WC-0167
Address of the Firm :
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2022-04-22
Registration Number : 20220422-209-J-1276
Manufacturer Name : Mangalam Drugs and Organics Ltd. (Unit-2)
Manufacturer Address : PLOT NO. 1203, PHASE-III, GIDC, VAPI-396 195, Dist. VALSAD, GUJARAT, INDA.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20813
Submission : 2007-08-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15566
Submission : 2001-07-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25302
Submission : 2011-08-16
Status : Active
Type : II
Certificate Number : R1-CEP 2002-046 - Rev 06
Status : Valid
Issue Date : 2019-05-03
Type : Chemical
Substance Number : 1548
Certificate Number : R1-CEP 2005-201 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2014-04-23
Type : Chemical
Substance Number : 1548
Certificate Number : R1-CEP 2004-117 - Rev 01
Status : Valid
Issue Date : 2015-11-13
Type : Chemical
Substance Number : 1548
Certificate Number : R1-CEP 2010-377 - Rev 02
Status : Valid
Issue Date : 2022-03-01
Type : Chemical
Substance Number : 1548
Certificate Number : R1-CEP 2011-310 - Rev 01
Status : Valid
Issue Date : 2023-03-13
Type : Chemical
Substance Number : 1548
Certificate Number : R0-CEP 2002-109 - Rev 01
Status : Expired
Issue Date : 2004-11-30
Type : Chemical
Substance Number : 1548
Certificate Number : R1-CEP 2001-350 - Rev 02
Status : Suspended by Holder
Issue Date : 2011-06-15
Type : Chemical
Substance Number : 1548
Date of Issue : 2019-09-03
Valid Till : 2022-09-02
Written Confirmation Number : WC-0251
Address of the Firm : Plot No. N-198, MIDC, Tarapur, Boisar, Tal. Palghar, Dist. Thane-401506, Mahrash...
Date of Issue : 2019-09-03
Valid Till : 2022-09-02
Written Confirmation Number : WC-251
Address of the Firm : Plot No. N-198, MIDC, Tarapur, Boisar, Tal. Palghar, Dist. Thane-401506, Mahrash...
Date of Issue : 2022-10-27
Valid Till : 2025-07-22
Written Confirmation Number : WC-0167
Address of the Firm : Unit No.1, Plot No.187, IInd Phase, GIDC Vapi-396195, Dist-Valsad, India
Date of Issue : 2020-06-11
Valid Till : 2023-06-10
Written Confirmation Number : WC-0473
Address of the Firm : Unit-2, Plot No.1203, III Phase, GIDC, Vapi-396 195, Dist-Valsad, Gujarat, India
Date of Issue : 2019-10-22
Valid Till : 2022-10-22
Written Confirmation Number : WC-303
Address of the Firm : Plot No.1416 to 1421, 1507/1&2&1601, IIIrd Phase, G.I.D.C Estate, VAPI 396195 Di...
Registrant Name : JDW Pharmaceutical Co., Ltd.
Registration Date : 2021-07-30
Registration Number : 20210730-209-J-1083
Manufacturer Name : Helsinn Advanced Synthesis S...
Manufacturer Address : Via Industria 24, 6710 Biasca, Switzerland
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2022-04-22
Registration Number : 20220422-209-J-1276
Manufacturer Name : Mangalam Drugs and Organics ...
Manufacturer Address : PLOT NO. 1203, PHASE-III, GIDC, VAPI-396 195, Dist. VALSAD, GUJARAT, INDA.
NDC Package Code : 17337-0533
Start Marketing Date : 2022-06-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Atman Pharmaceuticals is a fully integrated pharmaceutical company that has distinguished itself as a leader in Bulk Drugs (API) marketing both domestically in India and overseas. ...
About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healt...
About the Company : HELM Portugal is HELM’s Competence Centre for the marketing of Active Pharmaceutical Ingredients (API). The leading APIs distributed by Helm include Ascorbic Acid pharma Grade (C...
About the Company : Hoventa Pharma is in the business of manufacturing APIs for over three decades.We offer various kinds of services in addition to supplies of APIs, we undertake long-term contracts ...
About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...
About the Company : Pellets Pharma Limited is a fast growing organization established by a team of professionals with over decades of experience in the pharmaceutical industry with specific reference ...
About the Company : The technology of production of artemisinin and its derivatives is based on the use of cultivation of annual wormwood cells and extraction of artemisinin and artemisinic acid. Qual...
About the Company : Smaart Pharmaceutticals consciously strive for innovation through newer technologies, modern equipment available betterment of life and bring newer products for its customer. Smaa...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Through the agreement, Angelini Pharma will focus on commercializing Mesulid (nimesulide) in Europe. It is indicated for treating patients suffering from acute pain.
Lead Product(s): Nimesulide
Therapeutic Area: Neurology Brand Name: Mesulid
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Angelini Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement May 24, 2024
Lead Product(s) : Nimesulide
Therapeutic Area : Neurology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Angelini Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Helsinn and Angelini Renew Partnership for AULIN® and MESULID® in Central Europe
Details : Through the agreement, Angelini Pharma will focus on commercializing Mesulid (nimesulide) in Europe. It is indicated for treating patients suffering from acute pain.
Brand Name : Mesulid
Molecule Type : Small molecule
Upfront Cash : Undisclosed
May 24, 2024
Ortho Phenoxy Methane Sulfonanilide
CAS Number : 51765-51-6
End Use API : Nimesulide
About The Company : Mangalam Drugs & Organics Limited started manufacturing APIs and intermediates in 1977 in Gujarat, India. It has a multi-product manufacturing facility and an i...
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDES THINKS
Dosage Form : Granules For Oral Suspension
Dosage Strength : 100 mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDES THINKS
Dosage Form : Tablet
Dosage Strength : 100mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Generic
Registration Country : India
Brand Name : Monogesic
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Monogesic
Dosage Form : Gel
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info :
Registration Country : Italy
Brand Name : Algesil
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 bust grat 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sachet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDE SANDAZ
Dosage Form : Granules For Oral Solution
Dosage Strength : 100 mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Sulidamor
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDES THINKS
Dosage Form : Granules For Oral Suspension
Dosage Strength : 100 mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDES THINKS
Dosage Form : Tablet
Dosage Strength : 100mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDE EG
Dosage Form : Tablets
Dosage Strength : 100 mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 bust grat 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 bust grat 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 bust grat 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : NIMESULIDE SANDAZ
Dosage Form : Granules For Oral Solution
Dosage Strength : 100 mg
Packaging : 30 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 bust grat 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Nesulide
Dosage Form : Nimesulide 100Mg 30 Joined' Oral Use
Dosage Strength : 30 bust grat 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Erreflog
Dosage Form :
Dosage Strength : Collut 200 Ml 0.1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Generic
Registration Country : India
Brand Name : Monogesic
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 100MG
Brand Name : Monogesic
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Monogesic
Dosage Form : Gel
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Gel
Dosage Strength : 10MG
Brand Name : Monogesic
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : Nimgen
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 100MG
Brand Name : Nimgen
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name : NIMID
Dosage Form : GRANULES
Dosage Strength : 100MG/2G
Packaging : Glassine paper sachet
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging : Glassine paper sachet
Regulatory Info : Generic
Dosage : GRANULES
Dosage Strength : 100MG/2G
Brand Name : NIMID
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Nimesulide; Acetaminophen/Paracetamol
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG; 325MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Nimesulide; Acetaminophen/Paracetamol
Dosage : Tablet
Dosage Strength : 100MG; 325MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : NIMTOP-MD
Dosage Form : Mouth Dissolving Table...
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Mouth Dissolving Table...
Dosage Strength : 100MG
Brand Name : NIMTOP-MD
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sachet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Sachet
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
28 May 2024
// PHARMACEUTICAL TECHNOLOGY
https://www.pharmaceutical-technology.com/news/helsinn-angelini-distribution-deal/
14 Aug 2017
// ANVISA
https://www.pharmacompass.com/pdf/news/brainfarmas-batch-of-nimesulide-is-forbidden-by-anvisa-1502939899.pdf
21 Oct 2016
// REUTERS
http://www.reuters.com/article/us-health-nsaids-heart-failure-idUSKCN12K2J1
26 Apr 2016
// TWO FOUR INSIGHT
http://twofourinsight.com/experts-review-banned-drugs-consider-marketing-restrictions-india-mhfw/
27 Mar 2016
// PHARMA-EXCIPIENTS
http://www.pharma-excipients.ch/2016/03/27/impact-of-degree-of-substitution-of-acetylated-ofada-rice-starchpolymer-on-the-release-properties-of-nimesulide-microspheres/
18 Mar 2016
// ECONOMIC TIMES
http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/40-doctors-disagree-with-governments-recent-drug-ban-list-survey/articleshow/51459620.cms
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?